CLS Holdings USA, Inc. to Present at the Canaccord Genuity 2020 Virtual US Cannabis Symposium

Rhea-AI Summary

CLS Holdings USA (OTCQB:CLSH) will participate in the 2020 Virtual US Cannabis Symposium on September 30, 2020. President and COO Andrew Glashow is scheduled to present at 2:00 PM EDT, discussing the company's strides in cannabis innovation and sustainability amid COVID-19 challenges. CLS has sustained growth through its Oasis Cannabis subsidiary in Nevada, emphasizing a 'People Power Profits' approach. The company aims to expand its integrated cannabis operations, utilizing proprietary extraction methods for high-quality products.

LAS VEGAS, NV / ACCESSWIRE / September 28, 2020 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced its participation at the 2020 Virtual US Cannabis Symposium presented by Canaccord Genuity on September 30, 2020.

CLS is honored to present its expertise in cannabis innovation, strategic growth, and the expanding role of sustainability in being a good steward of the planet and industry. President and COO Andrew Glashow will be presenting via Zoom conference at 2:00PM EDT.

"We're thrilled to share our successes in growing our Nevada businesses sustainably and safely, despite the challenges presented this year. Our ‘People Power Profits' mantra has rung true for us time and time again. We're incredibly proud of our teams for allowing us the agility to maintain steady growth and a safe, comfortable environment for our customers throughout this year, and we can't wait to share the results of their efforts at this event." -Andrew Glashow, President/COO

CLS Holdings USA, Inc. President/COO Andrew Glashow

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. http://www.clsholdingsinc.com.

Twitter: @CLSHusa

Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named "Best Dispensary for Pot Pros" by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products. http://oasiscannabis.com

Photo: Oasis Cannabis Dispensary. Las Vegas, NV

Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada. https://citytrees.com

Photo: City Trees production facility, Las Vegas, NV

Forward Looking Statements

This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements''). These statements relate to, among other things, the future impact of the COVID-19 virus on our business, the future results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the future effect of our initiatives to expand market share and achieve growth during and following the pandemic, future results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material. In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.

Contact Information:

Corporate:
Chairman and CEO
Jeff Binder

President and COO
Andrew Glashow

888-438-9132

Investor Relations:
investors@clsholdingsinc.com

SOURCE: CLS Holdings USA, Inc.

View source version on accesswire.com:
https://www.accesswire.com/607776/CLS-Holdings-USA-Inc-to-Present-at-the-Canaccord-Genuity-2020-Virtual-US-Cannabis-Symposium

FAQ

What is CLS Holdings' participation in the 2020 Virtual US Cannabis Symposium?

CLS Holdings USA will present at the 2020 Virtual US Cannabis Symposium on September 30, 2020, focusing on cannabis innovation and sustainability.

Who will present for CLS Holdings at the symposium?

Andrew Glashow, President and COO of CLS Holdings, will present at the symposium.

What time will CLS Holdings present at the symposium?

CLS Holdings is scheduled to present at 2:00 PM EDT on September 30, 2020.

What is the main focus of CLS Holdings' presentation?

The presentation will cover CLS's expertise in cannabis innovation and strategic growth, particularly focusing on sustainability.

How has CLS Holdings maintained growth during COVID-19?

CLS Holdings has maintained growth through its 'People Power Profits' approach, adapting to challenges while ensuring a safe environment for customers.